YZi Labs Criticizes CEA Industries Again for Using "Poison Pill" Strategy and Defensive Charter Amendments

2026-01-07 04:42:47

Abstract generation in progress

Deep Tide TechFlow News, on January 7th, YZi Labs posted on social media stating that as a significant shareholder of CEA Industries (NASDAQ: BNC), YZi Labs is disappointed with the “poison pill plan” and the charter amendments restricting shareholder written consent adopted by the BNC Board of Directors. YZi Labs believes these measures are aimed at consolidating the board’s own position rather than protecting shareholder interests.

YZi Labs refuted BNC’s claim that “they have never considered alternative tokens,” pointing out that BNC CEO David Namdar explicitly stated at an industry conference in November 2025 that the company had considered switching to other cryptocurrencies such as Solana.

YZi Labs has submitted a preliminary consent statement to the U.S. Securities and Exchange Commission seeking to expand the BNC Board of Directors and elect its nominated directors. YZi Labs urges the board to ensure that the nomination and election process for the 2025 annual shareholders meeting is fair and transparent.

SOL-2,46%

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.